Sudeep Pharma IPO 2025: Robust Growth Potential with Comprehensive Insights
Sudeep Pharma IPO 2025: Robust Growth Potential with Comprehensive Insights
Introduction
Sudeep Pharma, a leading manufacturer of mineral-based pharmaceutical excipients, is set to launch its IPO during the period of November 21 to November 25, 2025. This article provides in-depth coverage of the IPO details, company overview, financial performance, and other essential insights for potential investors.
Company Overview
Founded in 1989, Sudeep Pharma specializes in producing mineral-based pharmaceutical excipients and food additives. The company has established a robust manufacturing facility with USFDA certification and services a global clientele of over 1,000 customers across 100 countries.
IPO Details
- IPO Type: Mainline IPO
- Issue Size: ₹895 Crores (₹95 Crores fresh issue + ₹800 Crores OFS)
- Price Band: ₹563 – ₹593 per share
- Lot Size: 25 shares
- GMP: ₹19 (indicating a strong potential listing gain)
- Open Date: November 21, 2025
- Close Date: November 25, 2025
- Listing Date: November 28, 2025
IPO Objectives
The proceeds from the IPO will be utilized primarily for capital expenditure, amounting to ₹75.8 Crores for procuring machinery and enhancing production capabilities.
Financial Highlights
Over the past three fiscal years, Sudeep Pharma has reported promising financial metrics:
- Revenue: ₹365 Crores in FY22, showing a YoY growth of 3.7%.
- PAT: Demonstrating growth with a 49% CAGR.
- ROE: Consistently positive, reflecting the company’s strong financial health.
Peer Comparison
In comparison with its peers, Sudeep Pharma boasts a profit margin of 27.63%, significantly higher than many global competitors who average below 15%.
Strengths
- Strong focus on quality and compliance in manufacturing processes.
- A diverse product portfolio catering to both pharmaceutical and food industries.
- Global reach with a robust customer base across multiple continents.
Risks
- Compliance with stringent regulations may restrict operational flexibility.
- Market dependence on raw material prices could impact profitability.
Expert Verdict
Overall, Sudeep Pharma’s IPO offers a compelling investment opportunity backed by consistent financial growth and a strong market position.
Subscription Status
As of the opening day, Sudeep Pharma’s IPO saw a subscription rate of 1.42 times, indicating high interest from retail and non-institutional investors.
Allotment & Listing Timeline
- Allotment Date: Expected by November 26, 2025
- Listing Date: November 28, 2025
FAQs
- How can I apply for the Sudeep Pharma IPO? Investors can apply through online trading platforms like Zerodha and ICICI Direct.
- What is the significance of GMP? The Grey Market Premium (GMP) indicates investor sentiment and potential gains on listing day.
How to Apply
Investors can find application links and detailed procedures on platforms like Zerodha and ICICI Direct.
